Prosecution Insights
Last updated: April 19, 2026

Florek & Endres Pllc

17 pending office actions • 12 clients

Portfolio Summary

17
Total Pending OAs
6
Final Rejections
11
Non-Final OAs

Client Portfolio (12 clients)

Client (Assignee)Pending OAs
Syremis Therapeutics, Ltd. 2
Envy Medical, Inc. 2
Allergan Sales, LLC 2
Brain Innovations, S.r.l. 2
Duravit Aktiengesellschaft 1
Centre National De La Recherche Scientifique 1
Vertice Pharma LLC 1
UNIVERSITA' DEGLI STUDI DI TRENTO 1
Montefibre Mae Technologies S.r.l. 1
Cardiomix S.r.l. 1
Handa Pharma, Inc. 1
Sifi S.p.A. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19419365 Untitled Syremis Therapeutics, Ltd. BORI, IBRAHIM D 1629 Non-Final OA
19419341 Untitled Syremis Therapeutics, Ltd. SZNAIDMAN, MARCOS L 1628 Non-Final OA
35522683 Faucet Duravit Aktiengesellschaft WOOD, SAMANTHA N 2914 Final Rejection Oct 02, 2024
18790134 MICRODERMABRASION SYSTEM WITH ERGONOMIC HANDLE Envy Medical, Inc. SHI, KATHERINE MENGLIN 3771 Non-Final OA Jul 31, 2024
18710778 MULTIPLEX CARS MICROSCOPY DEVICE Centre National De La Recherche Scientifique LAPAGE, MICHAEL P 2877 Final Rejection May 16, 2024
18585320 Microdermabrasion System With Combination Skin Therapies Envy Medical, Inc. HOAG, MITCHELL BRAIN 3771 Non-Final OA Feb 23, 2024
18570437 ADAPTER FOR CLINICAL, MEDICAL AND LABORATORY CONTAINERS Vertice Pharma LLC SMITH, PETER DANIEL 3781 Non-Final OA Dec 14, 2023
18290160 NOVEL QUINOLINE DERIVATIVES AND USES THEREOF UNIVERSITA' DEGLI STUDI DI TRENTO SEITZ, ANTHONY JOSEPH 1629 Non-Final OA Nov 10, 2023
18287457 ELECTROMAGNETIC WAVES MODULATING FILTER Unknown NIGAM, NATASHA 2872 Non-Final OA Oct 18, 2023
18458248 Topical Hyperpigmentation Compositions and Method of Use Allergan Sales, LLC CAIN, JENNIFER LYNN 1655 Non-Final OA Aug 30, 2023
18236682 PROCESS FOR THE RECOVERY AND RECYCLING OF UNREACTED MONOMER IN A SINGLE-STEP PROCESS FOR THE PRODUCTION OF A CARBON-FIBER PRECURSOR Montefibre Mae Technologies S.r.l. HUHN, RICHARD A 1764 Non-Final OA Aug 22, 2023
18278112 PROTEIN AND METABOLITE BLOOD BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME Cardiomix S.r.l. LIRIANO, MELISSA LIZETTE 1677 Non-Final OA Aug 21, 2023
18025092 METHOD FOR THE MANAGEMENT OF ORAL THERAPY IN PARKINSON'S DISEASE Brain Innovations, S.r.l. JACKSON, JORDAN L 2857 Final Rejection Mar 07, 2023
18025069 METHOD AND DEVICE FOR THE OBJECTIVE CHARACTERIZATION OF SYMPTOMS OF PARKINSON'S DISEASE Brain Innovations, S.r.l. TOMBERS, JOSEPH A 3791 Final Rejection Mar 07, 2023
18168310 STABLE VARENICLINE DOSAGE FORMS Handa Pharma, Inc. MATTISON, LORI K 1619 Non-Final OA Feb 13, 2023
17802588 FORMULATION BASED ON POLYHEXAMETHYLENE BIGUANIDE FOR USE IN THE TREATMENT OF ACANTHAMOEBA KERATITIS AND/OR FUNGAL INFECTIONS Sifi S.p.A. FAY, ZOHREH ALEMZADEH 1617 Final Rejection Aug 26, 2022
16965974 EXTRACELLULAR VESICLES DERIVED FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS AND USES THEREOF Allergan Sales, LLC BOECKELMAN, JACOB A 1655 Final Rejection Jul 29, 2020

Managing Florek & Endres Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month